Curcuminoid and Flavonoid Synergy for Inflammation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for inflammation, particularly in conditions like osteoarthritis and rheumatoid arthritis, are inadequate in effectively modulating metabolic processes triggered by bacterial endotoxins or LPS, which contribute to cartilage inflammation and degeneration.
Innovation Solution
A combination of curcuminoids and flavonoids, specifically curcumin, baicalin, and catechin, is used to create a formulation that synergistically reduces LPS-induced inflammatory pathways and cartilage degradation processes, offering both antioxidant and anti-inflammatory effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If single compounds (curcumin or flavonoids) are used to treat inflammation, then some anti-inflammatory effect is achieved, but the therapeutic effectiveness is insufficient and requires higher doses
Solution Approach 1:
The patent combines curcuminoids and flavonoids into a synergistic formulation where the two compound classes work together to achieve enhanced anti-inflammatory effectiveness. The combination allows for reduced individual doses while maintaining or improving therapeutic outcome, directly resolving the contradiction between effectiveness and dose requirement.
Solution Approach 2:
The invention creates a composite therapeutic formulation integrating multiple active ingredients (curcuminoids and flavonoids) that work synergistically. This composite approach enables better modulation of inflammatory pathways compared to single compounds, improving reliability while potentially reducing total substance quantity needed.
2Object-generated harmful factors
If conventional anti-inflammatory treatments are used, then inflammation is suppressed, but the metabolic processes underlying inflammation are not effectively modulated
Solution Approach 1:
The patent employs multiple compounds with different mechanisms of action that collectively modulate various metabolic parameters underlying inflammation. The curcuminoids and flavonoids together influence multiple enzymatic pathways, gene expression, and cellular processes, providing versatile modulation beyond simple inflammation suppression.
Solution Approach 2:
The combined formulation exhibits multi-functionality by simultaneously suppressing inflammation and modulating underlying metabolic processes. The curcuminoids and flavonoids work together to affect multiple biological targets including COX enzymes, LOX enzymes, NF-kB pathway, and various metabolic enzymes, achieving both immediate symptom relief and fundamental process modulation.
3Reliability
If higher doses of anti-inflammatory compounds are administered, then therapeutic effectiveness improves, but the complexity of formulation and dosing increases
Solution Approach 1:
By merging curcuminoids and flavonoids into a single synergistic formulation, the patent simplifies the dosing approach while maintaining or improving therapeutic effectiveness. The combination allows for a unified dosing regimen rather than managing multiple separate compounds, reducing formulation and dosing complexity.
Data Source
AI summary
Provided is a formulation and a method associated therewith for treating inflammation. The formulation includes therapeutically effective amounts of curcuminoids and two flavonoids. The two flavonoids include baicalin and catechin.